PH24227A - Sustained released pharmaceutical compositions - Google Patents

Sustained released pharmaceutical compositions

Info

Publication number: PH24227A
Authority: PH; Philippines
Prior art keywords: pharmaceutical compositions; sustained released; released pharmaceutical; sustained; compositions
Prior art date: 1986-10-09

Application number

PH35906A

Other languages

English (en)

Inventor

Henry C Gan

Original Assignee

Sandoz Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-10-09

Filing date

1987-10-08

Publication date

1990-05-04

1987-10-08 Application filed by Sandoz Ltd filed Critical Sandoz Ltd

1990-05-04 Publication of PH24227A publication Critical patent/PH24227A/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

PH35906A 1986-10-09 1987-10-08 Sustained released pharmaceutical compositions PH24227A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB868624213A GB8624213D0 (en)	1986-10-09	1986-10-09	Sustained release pharmaceutical compositions

Publications (1)

Publication Number	Publication Date
PH24227A true PH24227A (en)	1990-05-04

Family

ID=10605478

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PH35906A PH24227A (en)	1986-10-09	1987-10-08	Sustained released pharmaceutical compositions

Country Status (24)

Country	Link
JP (1)	JPS63101334A (ko)
KR (1)	KR880004801A (ko)
AU (1)	AU7942087A (ko)
BE (1)	BE1000732A5 (ko)
CA (1)	CA1332809C (ko)
CH (1)	CH675831A5 (ko)
DE (1)	DE3733540A1 (ko)
DK (1)	DK527487A (ko)
ES (1)	ES2014518A6 (ko)
FI (1)	FI874414A (ko)
FR (1)	FR2604902B1 (ko)
GB (2)	GB8624213D0 (ko)
GR (1)	GR871550B (ko)
HU (1)	HU201875B (ko)
IL (1)	IL84104A0 (ko)
IT (1)	IT1221493B (ko)
LU (1)	LU87009A1 (ko)
NL (1)	NL8702294A (ko)
NO (1)	NO874200L (ko)
NZ (1)	NZ222083A (ko)
PH (1)	PH24227A (ko)
PT (1)	PT85880B (ko)
SE (1)	SE8703889L (ko)
ZA (1)	ZA877617B (ko)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5948437A (en) *	1996-05-23	1999-09-07	Zeneca Limited	Pharmaceutical compositions using thiazepine
US5895663A (en) *	1997-07-31	1999-04-20	L. Perrigo Company	Pseudoephedrine hydrochloride extended-release tablets
EP1169024B1 (en)	1999-03-31	2005-12-21	Janssen Pharmaceutica N.V.	Pregelatinized starch in a controlled release formulation
US6242003B1 (en)	2000-04-13	2001-06-05	Novartis Ag	Organic compounds
US20060127474A1 (en)	2001-04-11	2006-06-15	Oskar Kalb	Pharmaceutical compositions comprising fluvastatin
SE0102886D0 (sv) *	2001-08-29	2001-08-29	Astrazeneca Ab	New formulation
SE0102887D0 (sv) *	2001-08-29	2001-08-29	Astrazeneca Ab	New formulation
SE0102888D0 (sv) *	2001-08-29	2001-08-29	Astrazeneca Ab	New formulation
TWI338583B (en)	2004-05-20	2011-03-11	Otsuka Pharma Co Ltd	Solid pharmaceutical formulation
SI1803447T1 (sl) *	2004-09-09	2010-01-29	Psicofarma S A De C V	Farmacevtski sestavek za zadrĺ˝evano sproĺ äśanje hidralazina in njegova uporaba kot podrpora zdravljenju raka

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE795766A (fr) *	1972-02-22	1973-08-22	Lilly Co Eli	Particules de napsylate de propoxyphene retard et procede de fabrication de ces particules
US4389393A (en) *	1982-03-26	1983-06-21	Forest Laboratories, Inc.	Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4520009A (en) *	1983-11-28	1985-05-28	Verex Laboratories, Inc.	Sustained released aspirin formulation
DE3346571A1 (de) *	1983-12-23	1985-07-04	Bayer Ag, 5090 Leverkusen	Oral retardierte acetylsalicylsaeureformulierungen
KR850700212A (ko) *	1984-03-21	1985-12-26	죠지 드모트	서방성 약제학적 캼셀제

1986
- 1986-10-09 GB GB868624213A patent/GB8624213D0/en active Pending
1987
- 1987-09-25 NL NL8702294A patent/NL8702294A/nl not_active Application Discontinuation
- 1987-09-25 HU HU874311A patent/HU201875B/hu not_active IP Right Cessation
- 1987-10-02 FR FR878713759A patent/FR2604902B1/fr not_active Expired - Lifetime
- 1987-10-02 CH CH3838/87A patent/CH675831A5/de not_active IP Right Cessation
- 1987-10-02 BE BE8701131A patent/BE1000732A5/fr not_active IP Right Cessation
- 1987-10-03 DE DE19873733540 patent/DE3733540A1/de not_active Withdrawn
- 1987-10-06 IL IL84104A patent/IL84104A0/xx unknown
- 1987-10-06 LU LU87009A patent/LU87009A1/fr unknown
- 1987-10-06 KR KR870011168A patent/KR880004801A/ko not_active Application Discontinuation
- 1987-10-07 GB GB8723515A patent/GB2195893B/en not_active Expired - Lifetime
- 1987-10-07 PT PT85880A patent/PT85880B/pt not_active IP Right Cessation
- 1987-10-07 FI FI874414A patent/FI874414A/fi not_active IP Right Cessation
- 1987-10-07 GR GR871550A patent/GR871550B/el unknown
- 1987-10-07 NO NO874200A patent/NO874200L/no unknown
- 1987-10-07 NZ NZ222083A patent/NZ222083A/en unknown
- 1987-10-07 AU AU79420/87A patent/AU7942087A/en not_active Abandoned
- 1987-10-08 PH PH35906A patent/PH24227A/en unknown
- 1987-10-08 DK DK527487A patent/DK527487A/da not_active Application Discontinuation
- 1987-10-08 IT IT48469/87A patent/IT1221493B/it active
- 1987-10-08 SE SE8703889A patent/SE8703889L/ not_active Application Discontinuation
- 1987-10-08 CA CA000548872A patent/CA1332809C/en not_active Expired - Lifetime
- 1987-10-08 ES ES8702873A patent/ES2014518A6/es not_active Expired - Lifetime
- 1987-10-08 JP JP62256149A patent/JPS63101334A/ja active Pending
- 1987-10-09 ZA ZA877617A patent/ZA877617B/xx unknown

Also Published As

Publication number	Publication date
FI874414A (fi)	1988-04-10
SE8703889D0 (sv)	1987-10-08
GB2195893A (en)	1988-04-20
PT85880A (en)	1987-11-01
IT1221493B (it)	1990-07-06
GB8723515D0 (en)	1987-11-11
NL8702294A (nl)	1988-05-02
ZA877617B (en)	1989-05-30
KR880004801A (ko)	1988-06-27
NZ222083A (en)	1991-05-28
DK527487D0 (da)	1987-10-08
PT85880B (pt)	1990-07-31
CA1332809C (en)	1994-11-01
DE3733540A1 (de)	1988-04-14
DK527487A (da)	1988-04-10
GB2195893B (en)	1991-05-08
FR2604902B1 (fr)	1991-04-26
LU87009A1 (fr)	1988-05-03
JPS63101334A (ja)	1988-05-06
IT8748469A0 (it)	1987-10-08
GR871550B (en)	1988-02-15
NO874200L (no)	1988-04-11
BE1000732A5 (fr)	1989-03-21
HU201875B (en)	1991-01-28
IL84104A0 (en)	1988-03-31
FR2604902A1 (fr)	1988-04-15
NO874200D0 (no)	1987-10-07
CH675831A5 (ko)	1990-11-15
ES2014518A6 (es)	1990-07-16
FI874414A0 (fi)	1987-10-07
SE8703889L (sv)	1988-04-10
HUT52958A (en)	1990-09-28
AU7942087A (en)	1988-04-14
GB8624213D0 (en)	1986-11-12

Publication	Publication Date	Title
GB2196964B (en)	1990-07-18	Pharmaceutical compositions
GB8716301D0 (en)	1987-08-19	Pharmaceutical compositions
GB8717582D0 (en)	1987-09-03	Pharmaceutical compositions
GB8723121D0 (en)	1987-11-04	Pharmaceutical compositions
GB8714625D0 (en)	1987-07-29	Pharmaceutical compositions
GB8608818D0 (en)	1986-05-14	Pharmaceutical compositions
GB8717581D0 (en)	1987-09-03	Pharmaceutical compositions
GB8618259D0 (en)	1986-09-03	Pharmaceutical compositions
GB2191696B (en)	1991-01-16	Pharmaceutical compositions
GB2190838B (en)	1990-12-12	Pharmaceutical compositions
GB8629781D0 (en)	1987-01-21	Pharmaceutical compositions
GB8723120D0 (en)	1987-11-04	Pharmaceutical compositions
PH24227A (en)	1990-05-04	Sustained released pharmaceutical compositions
GB8723118D0 (en)	1987-11-04	Pharmaceutical compositions
GB2188235B (en)	1990-11-14	Pharmaceutical compositions
GR871999B (en)	1988-04-26	Pharmaceutical compositions
GB8620073D0 (en)	1986-10-01	Pharmaceutical compositions
GB8621756D0 (en)	1986-10-15	Pharmaceutical compositions
GB8615041D0 (en)	1986-07-23	Pharmaceutical compositions
GB8624214D0 (en)	1986-11-12	Sustained release pharmaceutical compositions
GB8626216D0 (en)	1986-12-03	Pharmaceutical compositions
GB8611830D0 (en)	1986-06-25	Pharmaceutical compositions
GB8612806D0 (en)	1986-07-02	Pharmaceutical compositions
GB8616397D0 (en)	1986-08-13	Pharmaceutical compositions
GB8616695D0 (en)	1986-08-13	Pharmaceutical compositions